Attachment E1. 60-day FRN

Federal Register / Vol. 81, No. 140 / Thursday, July 21, 2016 / Notices
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than August 18,
2016.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Wintrust Financial Corporation,
Rosemont, Illinois; to acquire 100
percent of First Community Financial
Corporation, Elgin, Illinois, and thereby
indirectly acquire First Community
Bank, Elgin, Illinois.
B. Federal Reserve Bank of Kansas
City (Dennis Denney, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
1. Adage, LLC, Ogallala, Nebraska; to
become a bank holding company
through the acquisition of 68.85 percent
of the voting shares of Adbanc, Inc., and
thereby indirectly acquire Adams Bank
& Trust, both of Ogallala, Nebraska.
C. Federal Reserve Bank of San
Francisco (Gerald C. Tsai, Director,
Applications and Enforcement) 101
Market Street, San Francisco, California
94105–1579:
1. Luther Burbank Corporation, Santa
Rosa, California; to become a bank
holding company upon the conversion
of Luther Burbank Savings, Santa Rosa,
California, from a savings bank into a
commercial bank.
Board of Governors of the Federal Reserve
System, July 18, 2016.
Margaret Shanks,
Deputy Secretary of the Board.
asabaliauskas on DSK3SPTVN1PROD with NOTICES

[FR Doc. 2016–17271 Filed 7–20–16; 8:45 am]
BILLING CODE 6210–01–P

VerDate Sep<11>2014

17:15 Jul 20, 2016

Jkt 238001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–16–0215; Docket No. CDC–2016–
0066]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on the proposed revision of
the National Death Index (NDI). The
NDI is a national data base containing
identifying death record information
submitted annually to NCHS by all the
state vital statistics offices, beginning
with deaths in 1979. Searches against
the NDI file provide the states and dates
of death, and the death certificate
numbers of deceased study subjects.
Using the NDI Plus service, researchers
have the option of also receiving cause
of death information for deceased
subjects.
DATES: Written comments must be
received on or before September 19,
2016.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2016–
0066 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
SUMMARY:

PO 00000

Frm 00052

Fmt 4703

Sfmt 4703

47395

the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
National Death Index (NDI), (OMB
No. 0920–0215, Expiration 10/31/

E:\FR\FM\21JYN1.SGM

21JYN1

47396

Federal Register / Vol. 81, No. 140 / Thursday, July 21, 2016 / Notices

2016)—Revision—National Center for
Health Statistics (NCHS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C.), as
amended, authorizes that the Secretary
of Health and Human Services (DHHS),
acting through NCHS, shall collect
statistics on the extent and nature of
illness and disability of the population
of the United States.
The National Death Index (NDI) is a
national data base containing
identifying death record information
submitted annually to NCHS by all the
state vital statistics offices, beginning
with deaths in 1979. Searches against

update the three data collection forms
submitted by NDI users when applying
for use of the NDI and when actually
using the service. The form updates
include editorial changes needed to
capture current modes of data transfer
and service payment options, direction
clarifications, the inclusion of an item to
capture any resulting publications, as
well as, additional terms and condition
associated with the confidentiality
agreement. There is no cost to
respondents except for their time. The
total estimated annual burden hours are
507, an increase of 325 hours due to an
anticipated increase of both the number
of applicants and an overall average
increased time to complete the
application form.

the NDI file provide the states and dates
of death, and the death certificate
numbers of deceased study subjects.
Using the NDI Plus service,
researchers have the option of also
receiving cause of death information for
deceased subjects, thus reducing the
need to request copies of death
certificates from the states. The NDI
Plus option currently provides the
International Classification of Disease
(ICD) codes for the underlying and
multiple causes of death for the years
1979–2015. Health researchers must
complete administrative forms in order
to apply for NDI services, and submit
records of study subjects for computer
matching against the NDI file. A threeyear Revision request is submitted to

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total burden
hours

Form name

Researchers ......................................
Researchers ......................................
Researchers ......................................

Application Form ..............................
Repeat Request Form ......................
Data Transmittal Form .....................

100
70
120

1
1
1

4.5
18/60
18/60

450
21
36

Total ...........................................

...........................................................

........................

........................

........................

507

Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2016–17170 Filed 7–20–16; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2016–N–0001]

Advisory Committee; Science Board to
the Food and Drug Administration,
Renewal
AGENCY:

Food and Drug Administration,

HHS.
Notice; renewal of advisory
committee.

ACTION:

The Food and Drug
Administration (FDA) is announcing the
renewal of the Science Board to the
Food and Drug Administration by the
Commissioner of Food and Drugs (the
Commissioner). The Commissioner has
determined that it is in the public
interest to renew the Science Board to
the Food and Drug Administration for
an additional 2 years beyond the charter

SUMMARY:
asabaliauskas on DSK3SPTVN1PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Type of respondent

VerDate Sep<11>2014

17:15 Jul 20, 2016

Jkt 238001

expiration date. The new charter will be
in effect until June 26, 2018.
DATES: Authority for the Science Board
to the Food and Drug Administration
will expire on June 26, 2018, unless the
Commissioner formally determines that
renewal is in the public interest.
FOR FURTHER INFORMATION CONTACT:
Rakesh Raghuwanshi, Office of the
Chief Scientist, Office of the
Commissioner, Food and Drug
Administration, Bldg. 1, Rm. 3309,
10903 New Hampshire Ave., Silver
Spring, MD 20993, 301–796–4769,
rakesh.raghuwanshi@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to 41 CFR 102–3.65 and approval by the
Department of Health and Human
Services pursuant to 45 CFR part 11 and
by the General Services Administration,
FDA is announcing the renewal of the
Science Board to the Food and Drug
Administration. The committee is a
discretionary Federal advisory
committee established to provide advice
to the Commissioner. The Science Board
advises the Commissioner or designee
in discharging responsibilities as they
relate to helping to ensure safe and
effective drugs for human use and, as
required, any other product for which
FDA has regulatory responsibility. The
Science Board shall provide advice to
the Commissioner and other appropriate
officials on specific complex scientific

PO 00000

Frm 00053

Fmt 4703

Sfmt 4703

and technical issues important to FDA
and its mission, including emerging
issues within the scientific community.
Additionally, the Science Board will
provide advice that supports the Agency
in keeping pace with technical and
scientific developments, including in
regulatory science; and input into the
Agency’s research agenda; and on
upgrading its scientific and research
facilities and training opportunities. It
will also provide, where requested,
expert review of Agency-sponsored
intramural and extramural scientific
research programs.
The Committee shall consist of a core
of 21 voting members including a Chair
and Co-Chair. The members, Chair and
Co-Chair are selected by the
Commissioner or designee from among
authorities knowledgeable in the fields
of food science, safety, and nutrition;
chemistry; pharmacology; translational
and clinical medicine and research;
toxicology; biostatistics; medical
devices; imaging; robotics; cell and
tissue based products; regenerative
medicine; public health and
epidemiology; international health and
regulation; product safety; product
manufacturing sciences and quality; and
other scientific areas relevant to FDA
regulated products such as systems
biology, informatics, nanotechnology,
and combination products. Members

E:\FR\FM\21JYN1.SGM

21JYN1